GSK

TIDMGSK

RNS Number : 4384O

GSK PLC

01 February 2023

GSK plc

Total Voting Rights and Capital

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:

The Company's issued share capital as at 31 January 2023 consisted of 4,311,803,712 shares of 31 1/4 pence each ('Ordinary Shares'), of which 217,124,760 Ordinary Shares were held in Treasury.

Therefore, the total number of voting rights in the Company is 4,094,678,952. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Notifications may be sent to company.secretary@gsk.com .

V A Whyte

Company Secretary

1 February 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRBDGDBBDXDGXB

(END) Dow Jones Newswires

February 01, 2023 10:00 ET (15:00 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2023 to Mar 2023

Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2022 to Mar 2023